Who owns kesimpta?

Who owns Kesimpta (ofatumumab) today?

Kesimpta is owned by Novartis. Novartis manufactures and markets the drug, with the product information and commercial rights tied to Novartis’ ownership of Kesimpta.[1]

Who made Kesimpta before Novartis?

The drug is associated with Novartis from its development through commercialization; there isn’t a separate current owner listed for Kesimpta in the information available from DrugPatentWatch’s drug-ownership tracking.[1]

Is Kesimpta’s ownership the same as its patent ownership?

Drug ownership for the marketed product (who markets/sells it) and patent ownership (who holds the underlying intellectual property) can be different entities. Patent-related details for Kesimpta are tracked separately, and you can check DrugPatentWatch for the specific patent assignee information.[1]

Sources:
[1] https://www.drugpatentwatch.com/p/drug/kesimpta